कृपया अन्य खोज का प्रयास करें
Perseus Proteomics Inc., a drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery activities; and antibody research support activities comprising hybridoma antibody sequencing, antibody protein production, and contract antibody research activities, as well as supply of antibody products. Its product pipeline includes PPMX-T001, an anti-hepatocarcinoma antibody; PPMX-T002, an anticancer drug; PPMX-T003, a drug for the treatment of adult T-cell; and PPMX-T004, an antibody drug conjugate. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Shinichi Suzukawa | 68 | 2019 | Head of Administrative Dept, Executive Officer & Director |
Shinji Hagiwara | 58 | 2022 | Executive Officer, Head of R&D Dept., Head of Business Development Dept. and Director |
Tatsuhiko Kodama | - | - | Member of Scientific Advisory Board |
Hiroyuki Aburatani | - | - | Member of the Scientific Advisory Board |
Toshiya Tanaka | - | - | Member of Scientific Advisory Board |
Kinichiro Kominami | 57 | 2018 | Independent Outside Director |
Takuya Yokokawa | 64 | 2018 | President, CEO, Executive Officer & Chairman |
Tadashi Horiuchi | 78 | 2019 | Independent Outside Director |
Nobuo Hanai | 71 | 2021 | Independent Outside Director |
Takashi Ohno | 55 | 2021 | Independent Outside Director |
Tatsuya Nagase | 68 | 2022 | Independent Outside Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है